Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massou

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
The Lancet. Public Health|March 26, 2026
Effectiveness and cost-effectiveness of a parenting programme to improve family wellbeing in England (TOGETHER): a multicentre, single-blind, randomised controlled trialRichard G Watt, Annemarie Lodder, Leandra Box, et al.
Rheumatology (Oxford, England)|July 26, 2023
Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods studyMelanie Sloan, Chris Wincup, Rupert Harwood, et al.
JMIR Research Protocols|October 31, 2025
Implementation, Experiences, Impact, and Costs of Artificial Intelligence in Chest Diagnostics: Protocol for a Mixed Methods EvaluationAngus I G Ramsay, Chris Sherlaw-Johnson, Kevin Herbert, et al.
Eclinicalmedicine|December 8, 2025
Procurement and early deployment of artificial intelligence tools for chest diagnostics in NHS services in England: a rapid, mixed method evaluationAngus I G Ramsay, Nadia Crellin, Rachel Lawrence, et al.
Rheumatology (Oxford, England)|December 18, 2023
Attribution of neuropsychiatric symptoms and prioritization of evidence in the diagnosis of neuropsychiatric lupus: mixed methods analysis of patient and clinician perspectives from the international INSPIRE studyMelanie Sloan, Laura Andreoli, Michael S Zandi, et al.
Rheumatology (Oxford, England)|March 22, 2024
Neuropsychiatric symptoms in systemic lupus erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE projectMelanie Sloan, Thomas A Pollak, Efthalia Massou, et al.
Health Technology Assessment (Winchester, England)|November 15, 2024
Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysisNicola Curry, Ross Davenport, Helen Thomas, et al.
The Lancet. Microbe|May 11, 2022
Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in RwandaJean Claude Semuto Ngabonziza, Tom Decroo, Patrick Migambi, et al.
Nature Nanotechnology|November 29, 2016
Fluorescent nanodiamond tracking reveals intraneuronal transport abnormalities induced by brain-disease-related genetic risk factorsSimon Haziza, Nitin Mohan, Yann Loe-Mie, et al.
ERJ Open Research|March 11, 2026
Multicentre field evaluation of Xpert MTB/XDR in sub-Saharan AfricaFaridath Massou, Bassirou Diarra, Awa Ba Diallo, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
The Lancet. Public Health|March 26, 2026
Effectiveness and cost-effectiveness of a parenting programme to improve family wellbeing in England (TOGETHER): a multicentre, single-blind, randomised controlled trialRichard G Watt, Annemarie Lodder, Leandra Box, et al.
Rheumatology (Oxford, England)|July 26, 2023
Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods studyMelanie Sloan, Chris Wincup, Rupert Harwood, et al.
JMIR Research Protocols|October 31, 2025
Implementation, Experiences, Impact, and Costs of Artificial Intelligence in Chest Diagnostics: Protocol for a Mixed Methods EvaluationAngus I G Ramsay, Chris Sherlaw-Johnson, Kevin Herbert, et al.
Eclinicalmedicine|December 8, 2025
Procurement and early deployment of artificial intelligence tools for chest diagnostics in NHS services in England: a rapid, mixed method evaluationAngus I G Ramsay, Nadia Crellin, Rachel Lawrence, et al.
Rheumatology (Oxford, England)|December 18, 2023
Attribution of neuropsychiatric symptoms and prioritization of evidence in the diagnosis of neuropsychiatric lupus: mixed methods analysis of patient and clinician perspectives from the international INSPIRE studyMelanie Sloan, Laura Andreoli, Michael S Zandi, et al.
Rheumatology (Oxford, England)|March 22, 2024
Neuropsychiatric symptoms in systemic lupus erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE projectMelanie Sloan, Thomas A Pollak, Efthalia Massou, et al.
Health Technology Assessment (Winchester, England)|November 15, 2024
Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysisNicola Curry, Ross Davenport, Helen Thomas, et al.
The Lancet. Microbe|May 11, 2022
Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in RwandaJean Claude Semuto Ngabonziza, Tom Decroo, Patrick Migambi, et al.
Nature Nanotechnology|November 29, 2016
Fluorescent nanodiamond tracking reveals intraneuronal transport abnormalities induced by brain-disease-related genetic risk factorsSimon Haziza, Nitin Mohan, Yann Loe-Mie, et al.
ERJ Open Research|March 11, 2026
Multicentre field evaluation of Xpert MTB/XDR in sub-Saharan AfricaFaridath Massou, Bassirou Diarra, Awa Ba Diallo, et al.
Pageof 14